<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Referral</a></li><li><a href="#id2">Reason for Visit</a></li><li><a href="#id3">Encounter Details</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Medications at Time of Discharge</a></li><li><a href="#id6">Plan of Treatment</a></li><li><a href="#id7">Procedures</a></li><li><a href="#id8">Results</a></li><li><a href="#id9">Visit Diagnoses</a></li><li><a href="#id10">Administered Medications</a></li><li><a href="#id11">Additional Health Concerns</a></li><li><a href="#id12">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Referral</a></h3><div><ul><li>Preauthorization (Routine) - Closed: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td>Radiology</td><td><p>Diagnoses</p><p>Prostate cancer (HCC)</p><br/><p>Procedures</p><p>MRI Pelvis-Prostate W/  +  W/O Contrast</p></td><td><p>Stone, [REDACTED], [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>Phone: [REDACTED]</p><p>Fax: [REDACTED]</p></td><td><p/></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>20336852</td><td class="xflagData">Closed</td><td/><td>[REDACTED]</td><td>[REDACTED]</td><td>1</td><td>1</td></tr></tbody></table><br/><p>Electronically signed by [REDACTED] PA at [REDACTED]  4:32 PM EDT</p></li></ul></div><h3><a name="id2" href="#toc">Reason for Visit</a></h3><div><ul><li>Preauthorization (Routine) - Closed: <table><colgroup><col span="4" width="25%"/></colgroup><thead><tr><th>Specialty</th><th>Diagnoses / Procedures</th><th>Referred By Contact</th><th>Referred To Contact</th></tr></thead><tbody><tr><td>Radiology</td><td><p>Diagnoses</p><p>Prostate cancer (HCC)</p><br/><p>Procedures</p><p>MRI Pelvis-Prostate W/  +  W/O Contrast</p></td><td><p>Stone, [REDACTED], [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>Phone: [REDACTED]</p><p>Fax: [REDACTED]</p></td><td><p/></td></tr></tbody></table><table><colgroup><col width="13%"/><col width="12%"/><col width="25%"/><col width="13%"/><col width="12%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Referral ID</th><th>Status</th><th>Reason</th><th>Start Date</th><th>Expiration Date</th><th>Visits Requested</th><th>Visits Authorized</th></tr></thead><tbody><tr><td>20336852</td><td class="xflagData">Closed</td><td/><td>[REDACTED]</td><td>[REDACTED]</td><td>1</td><td>1</td></tr></tbody></table><br/></li></ul></div><h3><a name="id3" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col span="3" width="25%"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter3" class="xRowNormal"><td>[REDACTED]  4:32 PM EDT - [REDACTED] 11:59 PM EDT</td><td ID="encounter3type">Hospital Encounter</td><td><p>UHealth Imaging Services at Plantation</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td/><td><span class="content_span">Prostate cancer (HCC)</span><br/>Discharge Disposition: Home or Self Care - 01</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><table ID="sochist7"><colgroup><col span="2" width="25%"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never</td><td/><td ID="sochist7packsperday"/><td/><td/></tr><tr class="xRowAlt"><td>Passive Smoke Exposure: Never</td><td/><td/><td/><td/></tr><tr ID="sochist7smokeless" class="xRowNormal"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><colgroup><col span="2" width="25%"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Not Currently</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table ID="sdohassess1"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Humiliation, Afraid, Rape, and Kick questionnaire</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess1pair1"><td ID="sdohassess1pair1ques">Within the last year, have you been afraid of your partner or ex-partner?</td><td ID="sdohassess1pair1ans">No</td><td>[REDACTED]</td></tr><tr ID="sdohassess1pair2"><td ID="sdohassess1pair2ques">Within the last year, have you been humiliated or emotionally abused in other ways by your partner or ex-partner?</td><td ID="sdohassess1pair2ans">No</td><td>[REDACTED]</td></tr><tr ID="sdohassess1pair3"><td ID="sdohassess1pair3ques">Within the last year, have you been kicked, hit, slapped, or otherwise physically hurt by your partner or ex-partner?</td><td ID="sdohassess1pair3ans">No</td><td>[REDACTED]</td></tr><tr ID="sdohassess1pair4"><td ID="sdohassess1pair4ques">Within the last year, have you been raped or forced to have any kind of sexual activity by your partner or ex-partner?</td><td ID="sdohassess1pair4ans">No</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess2"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Social Connection and Isolation Panel [NHANES]</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess2pair1"><td ID="sdohassess2pair1ques">In a typical week, how many times do you talk on the phone with family, friends, or neighbors?</td><td ID="sdohassess2pair1ans">More than three times a week</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair2"><td ID="sdohassess2pair2ques">How often do you get together with friends or relatives?</td><td ID="sdohassess2pair2ans">More than three times a week</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair3"><td ID="sdohassess2pair3ques">How often do you attend church or religious services?</td><td ID="sdohassess2pair3ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair4"><td ID="sdohassess2pair4ques">Do you belong to any clubs or organizations such as church groups, unions, fraternal or athletic groups, or school groups?</td><td ID="sdohassess2pair4ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair5"><td ID="sdohassess2pair5ques">How often do you attend meetings of the clubs or organizations you belong to?</td><td ID="sdohassess2pair5ans">Patient declined</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair6"><td ID="sdohassess2pair6ques">Marital Status</td><td ID="sdohassess2pair6ans">Not on file</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess3"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>AUDIT-C</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess3pair1"><td ID="sdohassess3pair1ques">Q1: How often do you have a drink containing alcohol?</td><td ID="sdohassess3pair1ans">Never</td><td>[REDACTED]</td></tr><tr ID="sdohassess3pair2"><td ID="sdohassess3pair2ques">Average Number of Drinks</td><td ID="sdohassess3pair2ans">Not on file</td><td>[REDACTED]</td></tr><tr ID="sdohassess3pair3"><td ID="sdohassess3pair3ques">Q3: How often do you have six or more drinks on one occasion?</td><td ID="sdohassess3pair3ans">Never</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess5"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Overall Financial Resource Strain (CARDIA)</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess5pair1"><td ID="sdohassess5pair1ques">How hard is it for you to pay for the very basics like food, housing, medical care, and heating?</td><td ID="sdohassess5pair1ans">Not hard at all</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess6"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>PHQ-2</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess6pair1"><td ID="sdohassess6pair1ques">PHQ-9 Total Score</td><td ID="sdohassess6pair1ans">0</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess7"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Finnish Institute of Occupational Health - Occupational Stress Questionnaire</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess7pair1"><td ID="sdohassess7pair1ques">Do you feel stress - tense, restless, nervous, or anxious, or unable to sleep at night because your mind is troubled all the time - these days?</td><td ID="sdohassess7pair1ans">Not at all</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess8"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Hunger Vital Sign</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess8pair1"><td ID="sdohassess8pair1ques">Within the past 12 months, you worried that your food would run out before you got the money to buy more.</td><td ID="sdohassess8pair1ans">Never true</td><td>[REDACTED]</td></tr><tr ID="sdohassess8pair2"><td ID="sdohassess8pair2ques">Within the past 12 months, the food you bought just didn't last and you didn't have money to get more.</td><td ID="sdohassess8pair2ans">Never true</td><td>[REDACTED]</td></tr></tbody></table><table ID="sdohassess9"><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>PRAPARE - Transportation</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess9pair1"><td ID="sdohassess9pair1ques">In the past 12 months, has lack of transportation kept you from medical appointments or from getting medications?</td><td ID="sdohassess9pair1ans">No</td><td>[REDACTED]</td></tr><tr ID="sdohassess9pair2"><td ID="sdohassess9pair2ques">In the past 12 months, has lack of transportation kept you from meetings, work, or from getting things needed for daily living?</td><td ID="sdohassess9pair2ans">No</td><td>[REDACTED]</td></tr></tbody></table><table><colgroup><col width="50%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex10"><td>Sex Assigned at Birth</td><td ID="BirthSex10Value">Male</td><td>[REDACTED] 11:31 AM EST</td></tr><tr ID="GenderIdentity8"><td>Gender Identity</td><td ID="GenderIdentity8Value">Male</td><td>[REDACTED] 11:31 AM EST</td></tr><tr ID="SexualOrientation9"><td>Sexual Orientation</td><td ID="SexualOrientation9Value">Straight</td><td>[REDACTED] 11:31 AM EST</td></tr></tbody></table><table><colgroup><col span="2" width="25%"/><col width="50%"/></colgroup><thead><tr><th>Job Start Date</th><th>Occupation</th><th>Industry</th></tr></thead><tbody><tr><td>Not on file</td><td ID="sochist11">Not on file</td><td ID="sochist12">Not on file</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id5" href="#toc">Medications at Time of Discharge</a></h3><div><table><colgroup><col span="2" width="25%"/><col width="13%"/><col span="2" width="12%"/><col width="13%"/></colgroup><thead><tr><th>Medication</th><th>Sig</th><th>Dispensed</th><th>Refills</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr ID="dcrx24" class="xRowNormal"><td><p>CALCIUM-VITAMIN D PO</p></td><td ID="sig24">Take 2 tablets by mouth daily.</td><td/><td>0</td><td/><td/></tr><tr ID="dcrx28" class="xRowAlt"><td><p>amlodipine-olmesartan (AZOR) 10-40 MG per tablet</p></td><td ID="sig28">Take 1 tablet by mouth daily.</td><td/><td>0</td><td>[REDACTED]</td><td/></tr><tr ID="dcrx29" class="xRowNormal"><td><p>finasteride (PROSCAR) 5 MG tablet</p></td><td ID="sig29">Take 5 mg by mouth daily.</td><td/><td>0</td><td>[REDACTED]</td><td/></tr><tr ID="dcrx30" class="xRowAlt"><td><p>tamsulosin (FLOMAX) 0.4 MG CAPS capsule</p></td><td ID="sig30">Take 0.4 mg by mouth daily.</td><td/><td>0</td><td>[REDACTED]</td><td/></tr><tr ID="dcrx20" class="xRowNormal"><td><p>zolpidem (AMBIEN) 10 MG tablet</p></td><td ID="sig20"/><td/><td>0</td><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr ID="dcrx21" class="xRowAlt"><td><p>abiraterone (ZYTIGA) 250 MG tablet</p><content class="xallIndent">Indications: <span class="content_span">Metastatic Malignant Neoplasm of Prostate</span></content></td><td ID="sig21">Take 4 tablets by mouth daily for 90 days. Take on an empty stomach  Indications: Cancer of Prostate that has Spread to Other Part of Body</td><td><p>360 tablet</p></td><td>0</td><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr ID="dcrx23" class="xRowNormal"><td><p>Vitamin D, Cholecalciferol, 25 MCG (1000 UT) CAPS</p></td><td ID="sig23">Take 1 tablet by mouth daily for 90 days.</td><td><p>90 capsule</p></td><td>1</td><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr ID="dcrx25" class="xRowAlt"><td><p>predniSONE (DELTASONE) 5 MG tablet</p><content class="xallIndent">Indications: <span class="content_span">Prostate cancer (HCC)</span></content></td><td ID="sig25">Take 1 tablet by mouth 2 times daily. Take only while on abiraterone</td><td><p>180 tablet</p></td><td>1</td><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr ID="dcrx27" class="xRowNormal"><td><p>VITAMIN D, ERGOCALCIFEROL, PO</p></td><td ID="sig27">Take 1,000 Units by mouth daily. With calcium</td><td/><td>0</td><td/><td>[REDACTED]</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id6" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col span="3" width="25%"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter44" class="xRowNormal"><td>[REDACTED]  8:15 AM EDT</td><td ID="encounter44type">Appointment</td><td><p>UHealth [REDACTED] at [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>STE 100</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED]-5701</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr><tr ID="encounter43" class="xRowAlt"><td>[REDACTED] 10:15 AM EDT</td><td ID="encounter43type">Appointment</td><td><p>UHealth [REDACTED] at [REDACTED]  Nuclear Medicine</p><p>[REDACTED][REDACTED]</p><p>STE 100</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED]-5701</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr><tr ID="encounter42" class="xRowNormal"><td>[REDACTED] 11:00 AM EDT</td><td ID="encounter42type">Procedure visit</td><td><p>UHealth Urology at Plantation</p><p>[REDACTED]</p><p>PLANTATION, FL 33324</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>Suite 309</p><p>[REDACTED]-2137</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr><tr ID="encounter41" class="xRowAlt"><td>[REDACTED] 10:40 AM EDT</td><td ID="encounter41type">Office Visit</td><td><p>UHealth Oncology at [REDACTED] 2</p><p>[REDACTED]</p><p>Suite 202</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/></tr><tr ID="encounter40" class="xRowNormal"><td>[REDACTED] 10:00 AM EDT</td><td ID="encounter40type">Appointment</td><td><p>UMHC [REDACTED] at [REDACTED] Radiation Oncology</p><p>[REDACTED][REDACTED]</p><p>STE 100</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>Discharge Disposition: Home or Self Care - 01</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id7" href="#toc">Procedures</a></h3><div><table><colgroup><col width="25%"/><col width="10%"/><col width="15%"/><col span="2" width="25%"/></colgroup><thead><tr><th>Procedure Name</th><th>Priority</th><th>Date/Time</th><th>Associated Diagnosis</th><th>Comments</th></tr></thead><tbody><tr ID="procedure49" class="xRowNormal"><td><span class="content_span">MRI PELVIS PROSTATE W PLUS WO CONTRAST</span></td><td>Routine</td><td>[REDACTED]  5:48 PM EDT</td><td><p>Prostate cancer (HCC)</p></td><td><p>Results for this procedure are in the <span class="xLink2-Result.1.2.840.114350.1.13.243.2.7.2.798268.223531587">results section</span>.</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id8" href="#toc">Results</a></h3><div><ul><li>MRI Pelvis-Prostate W/  +  W/O Contrast ([REDACTED]  5:48 PM EDT): <table><colgroup><col span="2" width="25%"/><col width="50%"/></colgroup><thead><tr><th>Anatomical Region</th><th>Laterality</th><th>Modality</th></tr></thead><tbody><tr><td>PROSTATE</td><td/><td>Magnetic Resonance</td></tr></tbody></table><table><colgroup><col span="5" width="20%"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.223531587.Specimen"/><td/><td/><td>[REDACTED]  9:11 AM EDT</td><td/></tr></tbody></table><table><thead><tr><th>Impressions</th></tr></thead><tbody><tr><td class="xpre"><p>[REDACTED]  4:46 PM EDT</p><p><span class="content_span">1.  Redemonstrated posttreatment changes of the prostate with mild interval increase in residual intermediate to low T2 signal involving both the peripheral and transition zones at the base of the prostatic gland. There are findings suggestive of </span><br/><span class="content_span">extraprostatic extension in the left lateral region.</span><br/><span class="content_span">2.  The posterior wall of the urinary bladder appears to be infiltrated by the prostatic mass.</span><br/><span class="content_span">3.  Redemonstrated osseous metastasis as described above.</span><br/><span class="content_span"> </span><br/><span class="content_span">I personally reviewed the images and the fellow/resident's findings, and I agree with the final report.</span><br/><span class="content_span"> </span><br/><span class="content_span">I personally reviewed the images and the resident's/fellow's findings and agree with the final report.</span></p></td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p>[REDACTED]  4:46 PM EDT</p><p><span class="content_span"> </span><br/><span class="content_span">PROCEDURE: MRI PELVIS PROSTATE W PLUS WO CONTRAST</span><br/><span class="content_span">EXAM DATE: [REDACTED] 4:54 PM </span><br/><span class="content_span"> </span><br/><span class="content_span">REASON FOR STUDY: 3T  DCE DWI 2.5 MM, RADIATION PROTOCOL</span><br/><span class="content_span">Additional history as per EMR: History of metastatic prostate cancer, with an MRI on 9/2022 showing a large BI-RADS 5 lesion with SV and bladder invasion, pelvic lymphadenopathy, and bone lesions. Pathology report shows 7 cores GS 4+4.</span><br/><span class="content_span"> </span><br/><span class="content_span">TECHNIQUE: Multiple parametric evaluation of the prostate/pelvis was performed without and with gadolinium base IV contrast.</span><br/><span class="content_span"> </span><br/><span class="content_span">COMPARISON: MR [REDACTED]</span><br/><span class="content_span">CORRELATION: Ga68 PSMA PET/CT [REDACTED]</span><br/><span class="content_span"> </span><br/><span class="content_span">PSA ultrasensitive level: 0.22 ng/ mL on [REDACTED]</span><br/><span class="content_span"> </span><br/><span class="content_span">FINDINGS:</span><br/><span class="content_span">Prostate Size: 3.1 x 3.3 x 4.4 cm. </span><br/><span class="content_span">Volume: 23 cc</span><br/><span class="content_span"> </span><br/><span class="content_span">Prostate: Redemonstrated extensive posttreatment changes with mild interval increase in size of the T2 inhomogeneously hyperintense nodular mass noted involving the entire remnant prostate with no evidence of associated restricted diffusion. </span><br/><span class="content_span"> </span><br/><span class="content_span">Extraprostatic extension: The prostatic capsule is not clearly visualized with evidence of direct tumor invasion noted involving the left lateral peripheral zone (4:15)</span><br/><span class="content_span"> </span><br/><span class="content_span">Seminal vesicles: Redemonstrated T2 hypointense signals in the bilateral seminal vesicles, in keeping with posttreatment effects. </span><br/><span class="content_span"> </span><br/><span class="content_span">Bladder: Partially distended bladder with redemonstrated diffuse bladder wall trabeculations, in keeping with chronic bladder outlet obstruction. There is loss of fat plane between the posterior wall of the bladder and the remnant prostate. Features </span><br/><span class="content_span">could be suggestive of bladder wall involvement. </span><br/><span class="content_span"> </span><br/><span class="content_span">Lymphadenopathy: No suspicious lymphadenopathy in the evaluated portions of the pelvis.</span><br/><span class="content_span"> </span><br/><span class="content_span">Bones: Redemonstrated T2 heterogenous lesions involving the pelvis, acetabulum and bilateral femoral heads, in keeping bone metastasis.</span><br/><span class="content_span"> </span><br/><span class="content_span">Other: Visualized segments of the rectum are unremarkable.</span><br/><span class="content_span"> </span></p></td></tr></tbody></table><table><thead><tr><th>Procedure Note</th></tr></thead><tbody><tr><td class="xnoIndent" ID="Result.1.2.840.114350.1.13.243.2.7.2.798268.223531587.ProcedureNote2761341746"><p>[REDACTED], MD - [REDACTED]</p><content><span class="xLabel">Formatting of this note might be different from the original.</span><br/><br/><span class="content_span">PROCEDURE: MRI PELVIS PROSTATE W PLUS WO CONTRAST</span><br/><span class="content_span">EXAM DATE: [REDACTED] 4:54 PM </span><br/><br/><span class="content_span">REASON FOR STUDY: 3T  DCE DWI 2.5 MM, RADIATION PROTOCOL</span><br/><span class="content_span">Additional history as per EMR: History of metastatic prostate cancer, with </span><span class="content_span">an MRI on 9/2022 showing a large BI-RADS 5 lesion with SV and bladder </span><span class="content_span">invasion, pelvic lymphadenopathy, and bone lesions. Pathology report shows </span><span class="content_span">7 cores GS 4+4.</span><br/><br/><span class="content_span">TECHNIQUE: Multiple parametric evaluation of the prostate/pelvis was </span><span class="content_span">performed without and with gadolinium base IV contrast.</span><br/><br/><span class="content_span">COMPARISON: MR [REDACTED]</span><br/><span class="content_span">CORRELATION: Ga68 PSMA PET/CT [REDACTED]</span><br/><br/><span class="content_span">PSA ultrasensitive level: 0.22 ng/ mL on [REDACTED]</span><br/><br/><span class="content_span">FINDINGS:</span><br/><span class="content_span">Prostate Size: 3.1 x 3.3 x 4.4 cm. </span><br/><span class="content_span">Volume: 23 cc</span><br/><br/><span class="content_span">Prostate: Redemonstrated extensive posttreatment changes with mild </span><span class="content_span">interval increase in size of the T2 inhomogeneously hyperintense nodular </span><span class="content_span">mass noted involving the entire remnant prostate with no evidence of </span><span class="content_span">associated restricted diffusion. </span><br/><br/><span class="content_span">Extraprostatic extension: The prostatic capsule is not clearly visualized </span><span class="content_span">with evidence of direct tumor invasion noted involving the left lateral </span><span class="content_span">peripheral zone (4:15)</span><br/><br/><span class="content_span">Seminal vesicles: Redemonstrated T2 hypointense signals in the bilateral </span><span class="content_span">seminal vesicles, in keeping with posttreatment effects. </span><br/><br/><span class="content_span">Bladder: Partially distended bladder with redemonstrated diffuse bladder </span><span class="content_span">wall trabeculations, in keeping with chronic bladder outlet obstruction. </span><span class="content_span">There is loss of fat plane between the posterior wall of the bladder and </span><span class="content_span">the remnant prostate. Features </span><br/><span class="content_span">could be suggestive of bladder wall involvement. </span><br/><br/><span class="content_span">Lymphadenopathy: No suspicious lymphadenopathy in the evaluated portions </span><span class="content_span">of the pelvis.</span><br/><br/><span class="content_span">Bones: Redemonstrated T2 heterogenous lesions involving the pelvis, </span><span class="content_span">acetabulum and bilateral femoral heads, in keeping bone metastasis.</span><br/><br/><span class="content_span">Other: Visualized segments of the rectum are unremarkable.</span><br/><br/><span class="content_span">IMPRESSION:</span><br/><span class="content_span">1.  Redemonstrated posttreatment changes of the prostate with mild </span><span class="content_span">interval increase in residual intermediate to low T2 signal involving both </span><span class="content_span">the peripheral and transition zones at the base of the prostatic gland. </span><span class="content_span">There are findings suggestive of </span><br/><span class="content_span">extraprostatic extension in the left lateral region.</span><br/><span class="content_span">2.  The posterior wall of the urinary bladder appears to be infiltrated by </span><span class="content_span">the prostatic mass.</span><br/><span class="content_span">3.  Redemonstrated osseous metastasis as described above.</span><br/><br/><span class="content_span">I personally reviewed the images and the fellow/resident's findings, and I </span><span class="content_span">agree with the final report.</span><br/><br/><span class="content_span">I personally reviewed the images and the resident's/fellow's findings and </span><span class="content_span">agree with the final report.</span></content><br/></td></tr></tbody></table><table><colgroup><col width="20%"/><col width="80%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th></tr></thead><tbody><tr><td>[REDACTED] PA</td><td>IMG MRI ORDERABLES</td></tr></tbody></table></li></ul>documented in this encounter</div><h3><a name="id9" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx4" class="xRowNormal"><td><p><span class="content_span">Prostate cancer (HCC)</span></p><p>Malignant neoplasm of prostate</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id10" href="#toc">Administered Medications</a></h3><div><table ID="admMedTable55"><span style="font-weight:bold; ">Inactive Administered Medications - up to 3 most recent administrations</span><colgroup><col width="40%"/><col span="5" width="12%"/></colgroup><thead><tr><th>Medication Order</th><th>MAR Action</th><th>Action Date</th><th>Dose</th><th>Rate</th><th>Site</th></tr></thead><tbody><tr class="xRowNormal xmedRow"><td class="Rrule" rowspan="1"><p>gadobenate dimeglumine (MULTIHANCE) 529 MG/ML injection</p><p>Starting [REDACTED][REDACTED] at 1649, For 1 dose</p></td><td>Contrast Given</td><td>[REDACTED]  5:49 PM EDT</td><td>19 mLs</td><td> </td><td/></tr><tr class="xRowNormal xMergeUp"><td class="Rrule"/><td colspan="5"/></tr></tbody></table>documented in this encounter</div><h3><a name="id11" href="#toc">Additional Health Concerns</a></h3><div><table><colgroup><col span="2" width="50%"/></colgroup><thead><tr><th>Assessment</th><th>Noted Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="assessment1">PHQ-9 Depression Total Score: 0</td><td>[REDACTED]  1:14 PM EDT</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id12" href="#toc">Care Teams</a></h3><div><table ID="ct58"><colgroup><col span="3" width="25%"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>[REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED]</p><p>Ste# 110</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>PCP - General</td><td>Internal Medicine</td><td>[REDACTED]</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>